ANDA 88572, held by Abbott. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88572 (Pediatric Lta Kit), held by Abbott, was first approved by FDA on Jul 31, 1984, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pediatric Lta Kit2% ยท solution;topical | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters